microvue ch50 eq eia kit (Quidel)
Quidel is a verified supplier 
Quidel manufactures this product 
96
Structured Review
Quidel
microvue ch50 eq eia kit
Microvue Ch50 Eq Eia Kit, supplied by Quidel, used in various techniques. Bioz Stars score: 96/100, based on 25 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elisa+kit/CH50+Eq+ELISA/pmc13678011-114-2-1
Average 96 stars, based on 25 article reviews
Microvue Ch50 Eq Eia Kit, supplied by Quidel, used in various techniques. Bioz Stars score: 96/100, based on 25 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elisa+kit/CH50+Eq+ELISA/pmc13678011-114-2-1
Average 96 stars, based on 25 article reviews
microvue ch50 eq eia kit - by Bioz Stars,
2026-10
96/100 stars
Images
1) Product Images from "Distinct Pharmacodynamic Complement Biomarker Signatures Define Iptacopan and Pegcetacoplan Treatment in C3 Glomerulopathy"
Article Title: Distinct Pharmacodynamic Complement Biomarker Signatures Define Iptacopan and Pegcetacoplan Treatment in C3 Glomerulopathy
Journal: Kidney International Reports
doi: 10.1016/j.ekir.2026.107087
Figure Legend Snippet: Paired PD complement biomarker changes during iptacopan treatment
Techniques Used: Biomarker Discovery
Figure Legend Snippet: Paired PD complement biomarker changes during pegcetacoplan treatment
Techniques Used: Biomarker Discovery
Figure Legend Snippet: Pathway-based organization and patient-level interpretation of complement biomarkers during proximal complement inhibition. (a) Complement biomarkers are organized into 4 biologically related axes: C3 response, alternative pathway amplification and factor B turnover, terminal pathway control, and functional pathway activity. Pegcetacoplan inhibits C3/C3b, whereas iptacopan inhibits factor B. The curved arrow represents the alternative pathway amplification loop feeding back into C3 activation. (b) Patient-level classification of on-treatment pharmacodynamic biomarker profiles. LPDC, largely PD-concordant; PDC, PD-concordant; PDD, PD-discordant.
Techniques Used: Inhibition, Amplification, Control, Functional Assay, Activity Assay, Activation Assay, Biomarker Discovery
Figure Legend Snippet: Expected on-treatment pharmacodynamic biomarker patterns during factor B and C3/C3b inhibition
Techniques Used: Biomarker Discovery, Inhibition
Figure Legend Snippet: Pathway activity before and after proximal complement inhibition with iptacopan or pegcetacoplan. (a) Alternative pathway activity (APFA) was suppressed after treatment in both cohorts. Several patients had absent or near-absent APFA at baseline, creating a floor effect. (b) Classical pathway activity (CH50) increased after iptacopan and was generally preserved or increased after pegcetacoplan. With iptacopan, CH50 recovery is consistent with AP blockade and recovery of circulating C3. With pegcetacoplan, preserved or increased CH50 should not be interpreted in isolation as absence of target engagement. (c) Immunofixation electrophoresis of patient serum mixed 1:1 with normal human serum under EDTA or EGTA/MgCl 2 conditions. EDTA suppresses complement activation, whereas EGTA/MgCl 2 permits AP activation. At baseline, C3 activation products (C3AP) were detectable under EGTA/MgCl 2 conditions. After treatment, these products disappeared in both treatment groups, consistent with suppression of fluid-phase AP activation. In pegcetacoplan-treated samples, a slower-migrating C3-reactive band was observed, compatible with pegcetacoplan-bound C3 (Peg-C3). Filled circles with solid lines = PDC; open circles with dashed lines = LPDC; triangles = PDD. EDTA, ethylenediaminetetraacetic acid; EGTA, ethylene glycol tetraacetic acid; LPDC, largely PD-concordant; PDC, PD-concordant; PDD, PD-discordant.
Techniques Used: Activity Assay, Inhibition, Isolation, Drug discovery, Electrophoresis, Activation Assay
Figure Legend Snippet: Pegcetacoplan fully suppresses AP activity but incompletely suppresses CH50 in vitro . (a) Pegcetacoplan was added to pooled normal human serum at increasing molar ratios relative to C3. AP functional activity (red line), measured with the Wieslab AP assay, was completely suppressed at approximately a 1:1 pegcetacoplan:C3 molar ratio. In contrast, CH50 (blue line) decreased but remained detectable even at a 4:1 ratio, indicating different sensitivities of the two functional assays to pegcetacoplan. (b) C3 immunofixation electrophoresis showed a concentration-dependent increase in a slower-migrating band consistent with pegcetacoplan-bound C3 (Peg-C3) and a corresponding reduction in free C3. Free C3 remained detectable even in the presence of excess pegcetacoplan. Purified C3, shown as the circled dot in the second lane, served as an antibody control. (c) Addition of increasing concentrations of CP40, a competing C3-binding peptide, reduced the pegcetacoplan-C3 band and increased the free-C3 band, supporting concentration-dependent and reversible binding of pegcetacoplan to C3.
Techniques Used: Activity Assay, In Vitro, Functional Assay, Electrophoresis, Concentration Assay, Purification, Control, Binding Assay
Figure Legend Snippet: Biomarker profile in Peg#6 during pegcetacoplan treatment and after post-transplant switch to iptacopan
Techniques Used: Biomarker Discovery
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor survival in advanced pancreatic cancer. Article Snippet: .. YKL-40 levels were measured using an Article Title: Non-neuronal cholinergic stimulation favors bone mass accrual Article Snippet: Mechanical testing included the following machines: Instron 5569 (Instron Corp., Canton, MA, United States) and Vickers microhardness indenter machine (Clark CM100 AT, HT-CM-95605, Shawnee Mission, KS). .. Analyses of metabolic parameters included serum leptin ( Article Title: Proof-of-principle for enhanced dentoalveolar mineralization using exogenous tissue-nonspecific alkaline phosphatase in the Hyp mouse model of X-linked hypophosphatemia Article Snippet: Serum samples were analyzed at the clinical pathology laboratory at the College of Veterinary Medicine, The Ohio State University, to measure levels of calcium (Ca 2+ ), phosphate (P i ), and circulating alkaline phosphatase (ALP) activity. .. ELISA was employed to measure levels of FGF23 using Article Title: Association of CRP and synovial fluid HMGB1 with Pain in Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis: a cross-sectional study Article Snippet: Levels of IL-6 and IL-8 were determined using ELISA kits from R&D Systems (Minneapolis, MN, USA). .. The cartilage degradation marker C2C was measured using an Article Title: Genetic reduction or deletion of osteopontin in osteomalacic Hyp mice fails to ameliorate dentoalveolar defects Article Snippet: Serum from mice ( n = 5/genotype) was analyzed at the clinical pathology laboratory at the College of Veterinary Medicine (The Ohio State University) to analyze the levels of calcium, P i , and ALP in mouse serum. .. ELISA was performed to quantify levels of FGF23 using Article Title: Chronic Glomerular Thrombotic Microangiopathy in a 72-Year-Old Patient with B-Cell Chronic Lymphocytic Leukemia and IgG Lambda Paraprotein Article Snippet: .. The complement activation marker known as sC5b-9 was detected in EDTA plasma using a commercially available Article Title: Constitutive activation of TGF-β receptor type I promotes cortical and cancellous bone formation in adult mice Article Snippet: Serum phosphorus and calcium levels were measured according to the manufacturer’s instructions (Stanbio Laboratory, Boerne, TX, USA; catalog numbers 0830−125 and 0155−225, respectively). .. Parathyroid hormone (PTH) levels were quantified using a commercially available Catecholamine ELISA:Article Title: Non-neuronal cholinergic stimulation favors bone mass accrual Article Snippet: Mechanical testing included the following machines: Instron 5569 (Instron Corp., Canton, MA, United States) and Vickers microhardness indenter machine (Clark CM100 AT, HT-CM-95605, Shawnee Mission, KS). .. Analyses of metabolic parameters included serum leptin ( other:Article Title: Disruption of the FGFR1-FGF23-Phosphate Axis and Targeted Therapy in a Murine Model of Osteoglophonic Dysplasia Article Snippet: The inorganic phosphate concentrations for 18 WT and 6 Fgfr1 +/N330I mice were measured either by IDEXX BioAnalytics or by the Division of Veterinary Resources at the NIH. Marker:Article Title: Association of CRP and synovial fluid HMGB1 with Pain in Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis: a cross-sectional study Article Snippet: Levels of IL-6 and IL-8 were determined using ELISA kits from R&D Systems (Minneapolis, MN, USA). .. The cartilage degradation marker C2C was measured using an Article Title: Chronic Glomerular Thrombotic Microangiopathy in a 72-Year-Old Patient with B-Cell Chronic Lymphocytic Leukemia and IgG Lambda Paraprotein Article Snippet: .. The complement activation marker known as sC5b-9 was detected in EDTA plasma using a commercially available Activation Assay:Article Title: Chronic Glomerular Thrombotic Microangiopathy in a 72-Year-Old Patient with B-Cell Chronic Lymphocytic Leukemia and IgG Lambda Paraprotein Article Snippet: .. The complement activation marker known as sC5b-9 was detected in EDTA plasma using a commercially available Clinical Proteomics:Article Title: Chronic Glomerular Thrombotic Microangiopathy in a 72-Year-Old Patient with B-Cell Chronic Lymphocytic Leukemia and IgG Lambda Paraprotein Article Snippet: .. The complement activation marker known as sC5b-9 was detected in EDTA plasma using a commercially available |
